To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Monday, November 6, 2017
32% ...
...
of covered lives in the United States have access to Pulmozyme, a cystic
fibrosis drug, on the preferred tier. Pulmozyme is the most likely cystic
fibrosis drug to have preferred status.
No comments:
Post a Comment